In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme v. Atrium

This article was originally published in The Gray Sheet

Executive Summary

Cambridge, Massachusetts-based Genzyme Corp. and Genzyme Surgical Products file patent suit against Atrium Medical in Delaware district court Nov. 14 alleging Atrium's Express and Oasis chest drainage devices infringe certain patents, including those related to dry suction and/or dry seal technology. The patents relate to Genzyme's Pleur-Evac line of chest drainage systems. Genzyme seeks to prevent the continued manufacture of Express and Oasis until the patents expire, and will seek undetermined monetary awards
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT014141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel